Added value of MRI to endoscopic and endosonographic response assessment after neoadjuvant chemoradiotherapy in oesophageal cancer.
Sophie E VollenbrockJolanda M van DierenFrancine E M VonckenSietze T van TurenhoutLiudmila L KodachKoen J HarteminkJohanna W van SandickBerthe M P AlemanRegina G H Beets-TanAnnemarieke Bartels-RuttenPublished in: European radiology (2020)
• In this small study, the detection of residual tumour after neoadjuvant chemoradiotherapy in oesophageal cancer patients was improved by adding MRI including diffusion-weighted images to gastroscopy and endosonographic ultrasound. • With the addition of MRI assessment to gastroscopy and endosonographic ultrasound, the considerable risk of missing residual tumours decreased from 53 to 11%, while the pitfall was overstaging in one out of three complete responders.
Keyphrases
- contrast enhanced
- diffusion weighted
- rectal cancer
- magnetic resonance imaging
- locally advanced
- diffusion weighted imaging
- computed tomography
- magnetic resonance
- ultrasound guided
- lymph node
- squamous cell carcinoma
- radiation therapy
- deep learning
- papillary thyroid
- convolutional neural network
- optical coherence tomography
- real time pcr
- quantum dots